The EMA’s positive opinion on Kygevvi marks a turning point for patients with TK2d, an ultra-rare genetic muscle disease previously managed only with supportive care.
Aviva Private Clients has launched a new high-net-worth insurance proposition in the Lloyd’s market, enabling the business to offer bespoke cover for luxury properties and assets in countries such as ...